| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
From the Fourth Department of Internal Medicine (T.I., T.M., S.K.), Saitama Medical School, Saitama; Department of Cardiovascular Medicine (T.S.), Graduate School of Medicine, University of Tokyo; International Medical Center of Japan (Y.Y.), Tokyo; Division of Integrative Cell Biology, Department of Embryogenesis (H.K.), Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto; and Department of Biochemistry and Integrative Medical Biology (M.S.), School of Medicine, Keio University, Tokyo, Japan.
Correspondence to Toshisuke Morita, MD, PhD, Fourth Department of Internal Medicine, Saitama Medical School, 38 Morohongo, Moroyama, Iruma-Gun, Saitama 350-0495, Japan. E-mail toshijpn{at}saitama-med.ac.jp
Abstract
AbstractTo
elucidate pathophysiological roles of heme
oxygenase (HO)-1 in regulation of vascular tone in vivo, we
have developed and characterized transgenic (Tg) mice that overexpress
HO-1 site specifically in vascular smooth muscle cells (VSMCs). The Tg
mice were generated by use of human HO-1 cDNA under the control of
SM22-
promoter. The HO-1 gene overexpression was demonstrated by
Northern blot analysis and coincided with increases in the
protein expression in VSMCs and total HO activities. Tg mice exhibited
a significant increase in arterial pressure at various ages
and displayed impaired nitrovasodilatory responses in isolated aortic
segments versus nontransgenic littermates while enhancing their nitric
oxide (NO) production. The pressure of Tg mice was unchanged by
systemic administration of either
N
-nitro-L-arginine
or SNP. Furthermore, the isolated aorta in these mice exhibited lesser
extents of NO-elicited cGMP elevation via soluble guanylate
cyclase (sGC), while exhibiting no notable downregulation of sGC
expression. Such impairment of the NO-elicited cGMP increase was
restored significantly by tin protoporphyrin IX, an HO
inhibitor. On the other hand,
3-(5'-hydroxymethyl-2' furyl)-1-benzyl-indazol (YC-1), an
NO-independent activator of sGC, increased cGMP and relaxed
aortas from Tg mice to levels comparable with those from nontransgenic
mice, which indicates that contents of functionally intact sGC are
unlikely to differ between the two systems. These findings suggest that
site-specific overexpression of HO-1 in VSMCs suppresses vasodilatory
response to NO and thereby leads to an elevation of
arterial pressure.
Key Words: heme oxygenase-1 transgenic mice carbon monoxide soluble guanylate cyclase hypertension
This article has been cited by other articles:
![]() |
G. Alba, R. El Bekay, P. Chacon, M. E. Reyes, E. Ramos, J. Olivan, J. Jimenez, J. M. Lopez, J. Martin-Nieto, E. Pintado, et al. Heme oxygenase-1 expression is down-regulated by angiotensin II and under hypertension in human neutrophils J. Leukoc. Biol., August 1, 2008; 84(2): 397 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Mingone, M. Ahmad, S. A. Gupte, J. L. Chow, and M. S. Wolin Heme oxygenase-1 induction depletes heme and attenuates pulmonary artery relaxation and guanylate cyclase activation by nitric oxide Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1244 - H1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Stec, H. A. Drummond, and T. Vera Role of Carbon Monoxide in Blood Pressure Regulation Hypertension, March 1, 2008; 51(3): 597 - 604. [Full Text] [PDF] |
||||
![]() |
K. A. Nath, L. V. d'Uscio, J. P. Juncos, A. J. Croatt, M. C. Manriquez, S. T. Pittock, and Z. S. Katusic An analysis of the DOCA-salt model of hypertension in HO-1-/- mice and the Gunn rat Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H333 - H342. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Stocker and M. A. Perrella Heme Oxygenase-1: A Novel Drug Target for Atherosclerotic Diseases? Circulation, November 14, 2006; 114(20): 2178 - 2189. [Full Text] [PDF] |
||||
![]() |
R. Favory, S. Lancel, S. Tissier, D. Mathieu, B. Decoster, and R. Neviere Myocardial Dysfunction and Potential Cardiac Hypoxia in Rats Induced by Carbon Monoxide Inhalation Am. J. Respir. Crit. Care Med., August 1, 2006; 174(3): 320 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yano, R. Ozono, Y. Oishi, M. Kambe, M. Yoshizumi, T. Ishida, S. Omura, T. Oshima, and K. Igarashi Genetic ablation of the transcription repressor Bach1 leads to myocardial protection against ischemia/reperfusion in mice. Genes Cells, July 1, 2006; 11(7): 791 - 803. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-N. Liu, S.-L. Pan, C.-Y. Peng, J.-H. Guh, D.-M. Huang, Y.-L. Chang, C.-H. Lin, H.-C. Pai, S.-C. Kuo, F.-Y. Lee, et al. YC-1 [3-(5'-Hydroxymethyl-2'-furyl)-1-benzyl Indazole] Inhibits Neointima Formation in Balloon-Injured Rat Carotid through Suppression of Expressions and Activities of Matrix Metalloproteinases 2 and 9 J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 35 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ishikawa, M. Kajimura, T. Adachi, K. Maruyama, N. Makino, N. Goda, T. Yamaguchi, E. Sekizuka, and M. Suematsu Carbon Monoxide From Heme Oxygenase-2 Is a Tonic Regulator Against NO-Dependent Vasodilatation in the Adult Rat Cerebral Microcirculation Circ. Res., December 9, 2005; 97(12): e104 - e114. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Morita Heme Oxygenase and Atherosclerosis Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1786 - 1795. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Teran, R. A. Johnson, B. K. Stevenson, K. J. Peyton, K. E. Jackson, S. D. Appleton, W. Durante, and F. K. Johnson Heme oxygenase-derived carbon monoxide promotes arteriolar endothelial dysfunction and contributes to salt-induced hypertension in Dahl salt-sensitive rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2005; 288(3): R615 - R622. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-M. Hu, Y.-H. Chen, M.-T. Chiang, and L.-Y. Chau Heme Oxygenase-1 Inhibits Angiotensin II-Induced Cardiac Hypertrophy In Vitro and In Vivo Circulation, July 20, 2004; 110(3): 309 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cascalho, B. M. Ogle, and J. L. Platt Xenotransplantation and the Future of Renal Replacement J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1106 - 1112. [Full Text] [PDF] |
||||
![]() |
F. K. Johnson and R. A. Johnson Carbon monoxide promotes endothelium-dependent constriction of isolated gracilis muscle arterioles Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R536 - R541. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Araujo, L. Meng, A. D. Tward, W. W. Hancock, Y. Zhai, A. Lee, K. Ishikawa, S. Iyer, R. Buelow, R. W. Busuttil, et al. Systemic Rather Than Local Heme Oxygenase-1 Overexpression Improves Cardiac Allograft Outcomes in a New Transgenic Mouse J. Immunol., August 1, 2003; 171(3): 1572 - 1580. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Chen, S.-F. Yet, and M. A. Perrella Role of Heme Oxygenase-1 in the Regulation of Blood Pressure and Cardiac Function Experimental Biology and Medicine, May 1, 2003; 228(5): 447 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Braudeau, D. Bouchet, C. Toquet, L. Tesson, S. Menoret, S. Iyer, C. Laboisse, D. Willis, A. Jarry, R. Buelow, et al. Generation of Heme Oxygenase-1-Transgenic Rats Experimental Biology and Medicine, May 1, 2003; 228(5): 466 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, E. L. Bedard, R. Potter, R. Zhong, J. Alam, A. M. K. Choi, and P. J. Lee Mitogen-activated protein kinases regulate HO-1 gene transcription after ischemia-reperfusion lung injury Am J Physiol Lung Cell Mol Physiol, October 1, 2002; 283(4): L815 - L829. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Durante Carbon monoxide and bile pigments: surprising mediators of vascular function Vascular Medicine, August 1, 2002; 7(3): 195 - 202. [Abstract] [PDF] |
||||
![]() |
R. Holtwick, M. Gotthardt, B. Skryabin, M. Steinmetz, R. Potthast, B. Zetsche, R. E. Hammer, J. Herz, and M. Kuhn Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure PNAS, May 14, 2002; 99(10): 7142 - 7147. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Eckhart, T. Ozaki, H. Tevaearai, H. A. Rockman, and W. J. Koch Vascular-Targeted Overexpression of G Protein-Coupled Receptor Kinase-2 in Transgenic Mice Attenuates beta -Adrenergic Receptor Signaling and Increases Resting Blood Pressure Mol. Pharmacol., April 1, 2002; 61(4): 749 - 758. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |